april 11-13, 2018 | Moscow
CTERP INTERNATIONAL CONFERENCE
Translational Research in Cell Therapy
Welcome to the II International CTERP Conference. It meets the most acute demands of the burgeoning research activities both in novel cell therapy methods and disease mechanism understanding — iPSC, neurobiology, disease modelling, genome editing.

Recently passed law on cell technologies in Russia opens new perspectives for cell technology practical application but also calls for careful understanding of regulation requirements. Regulatory aspects in Russia and abroad will be discussed on the round table.


Registration is open till 31 March. If you would like to make an oral or poster presentation - submit your abstract till 28 February.
Adress
2 Presnenskaya Naberezhnaya
Novotel Moscow City, Moscow

Participation cost
from 2000 RUR

Registration is open >
New York, USA
Grigori Enikolopov
Professor at the Center for Developmental Genetics of Stony Brook University
Adjunct Professor at Cold Spring Harbor Laboratory
Adjunct Professor at Moscow Institute of Physics and Technology


Graduated in neurobiology and molecular biology from Moscow State University. Received his Ph.D. at the Institute of Molecular Biology in Moscow. Worked at the Institute of Molecular Biology, with training at the University of Zurich. Since 1989 worked at Cold Spring Harbor Laboratory, before recently joining Stony Brook University.

Research interests
  • stem cells of the adult brain
  • signals controlling division, differentiation, and maintenance of stem cells
Novosibirsk, Russia
Dmitry Zharkov
Doctor of Science in Biology
Novosibirsk State University, SB RAS Institute of Chemical Biology and Fundamental Medicine
Heads the Laboratory of Genome and Protein Engineering at SB RAS Institute of Chemical Biology and Fundamental Medicine
Director of the Interdisciplinary Center for Advanced Biomedical Research at Novosibirsk State University


  • 2015 - Russian Academy of Sciences Professorship.
  • 2015 - Russian Foundation for Basic Research Certificate of Honor for contribution to the development of science.
  • 2014 - Novosibirsk State University Certificate of Honor for lifetime contribution for the benefit of the University.
  • 2009 - Prize of the Government of Novosibirsk Region for achievements in science and technology.
  • 2007 - Russian Academy of Sciences Honorary Award for achievements in basic sciences and industry in Siberia.

Obtained a PhD in 1998 from the Stony Brook University, USA. From 1998 to 2001, he was a postdoc at the Department of Pharmacological Sciences, Stony Brook University and worked as a visiting scientist at the Weizmann Institute of Science, Israel. During his career, Dr. Zharkov contributed to the discovery of several DNA repair enzymes and understanding their mechanism of action through biochemical, structural, and computational studies.
Presently, he heads the Laboratory of Genome and Protein Engineering at SB RAS Institute of Chemical Biology and Fundamental Medicine, and is the director of the Interdisciplinary Center for Advanced Biomedical Research at Novosibirsk State University (NSU). He teaches Molecular Biology and Molecular Pharmacology at NSU.

Research interests:
  • Fundamental mechanisms of DNA damage, DNA repair and cell response to genotoxic stress.
  • Human diseases linked to genotoxic stress and DNA repair defects.
  • Development of molecular biology tools employing DNA repair enzymes.
  • Design of enzymes and protein/nucleic acid systems with predicted functions and properties.
  • Development of new tools for genome editing
Professional membership:
  • European Environmental Mutagen Society
  • Russian Biochemical Society
  • Yu. A. Ovchinnikov's Russian Society of Biotechnologists
    Moscow, Russia
    Sergei Nedospasov
    Doctor of Biological Sciences
    Professor
    Corresponding Member of the Russian Academy of Sciences
    Academician of the Russian Academy of Sciences
    Head of the Laboratory of Molecular Mechanisms of Immunity of the Institute of Molecular Biology, RAS
    Head of the Department of Molecular Immunology, Institute of Physico-Chemical Biology, RAS
    Head of the Department of Immunology, Biological Faculty, Moscow State University.
    Scientific Supervisor of the Laboratory of Experimental Immunology of the Center for Molecular Biology and Biomedicine, Institute of Biology and Biomedicine, Nizhny Novgorod State University


    • Graduated from Faculty of Molecular and Chemical Physics, Department of Molecular Biophysics.
    • From 1976 he worked in the laboratory of Acad. G.P. Georgieva in the Institute of Molecular Biology. Engelhardt of the Russian Academy of Sciences, then headed a scientific group and a laboratory at the same Institute.
    • In MSU - since 1996 (Institute of Physico-Chemical Biology named after AN Belozersky).
    • From 1995 to 2010 - International Research Scholar Medical Institute. Howard Hughes.
    • In 1980 he defended his Ph.D. thesis, in 1990 he obtained his doctoral thesis.
    • Since 1998, Professor. He is in charge of the Laboratory of Molecular Mechanisms of Immunity of the Institute of Molecular Biology, Russian Academy of Sciences. V. A. Engelhardt.
    Russian biologist, an expert in molecular biology and genetics, immunology and biotechnology. One of the top 100 most cited Russian scientists.

    He organized educational programs in Moscow on oncoimmunology and molecular immunology.
    Made a major contribution to the development of domestic molecular biology, immunology and biomedicine. He and his school carried out pioneering work on the biology of cytokines, created unique animal models of human diseases, investigated the mechanisms of pathogenesis of a number of diseases at the molecular level, developed new approaches to biotherapy, including the creation of prototypes for new drugs.
    In the 80 years, SA Nedospasov and colleagues were the first to molecularly clone the genes of the tumor necrosis factor (TNF) family of cytokines, which are the mediators of immune processes. Based on these molecular clones, cytokine production strains have been created in our country, including TNF and human lymphotoxin, and then a panel of monoclonal antibodies that neutralize their activity. SA Nedospasov and colleagues created a unique panel of mouse lines with controlled deactivation of TNF, lymphotoxin and other mediators important for the development of the immune system. In these animals it became possible to model various human diseases - from autoimmune and infectious to oncological, to study the association of microbiota with inflammation, and also to practice biotherapy.

    Published more than 200 articles, including in the leading international journals (Science, Nature, Immunity, Blood, etc.).

    Member of the editorial boards of international and domestic journals: European Journal of Immunology, Journal of Inflammation, Immunology Letters, Molecular Biology, Russian Immunological Journal, Medical Immunology, Cytology.

    Scientific interests:
    • mechanisms of innate immunity
    • physiology of cytokines
    • genetic knockout in mice and mouse models of human diseases
    • cancer antigens

    Awards
    • Investigator Award of the Institute of Cancer Research (USA, 1991)
    • Prize of the Berlin-Brandenburg Academy of Sciences (Germany, 2000)
    • The Helmholtz-Humboldt Prize (2005)
    • Elected a member of the European Academy (2010), the European Academy of Oncoimmunology (2012)
    • II Mechnikov Prize (2011) - For the cycle of scientific works "Molecular-cellular mechanisms of organization of human and mouse lymphoid organs" (jointly with AA Yarilin).
    • The State Prize of the Russian Federation (2015) - for a series of fundamental and applied works on the study of molecular mediators of immunity, including works on the creation of unique biomedical models.
    • Honorary Doctor of UNN. NN Lobachevsky (2016)
    Moscow, Russia
    Vladimir Baklaushev
    MD, PhD, DSc (med)
    Chief Scientific Officer Federal Research and Clinical Center, FMBA of Russia
    Professor of the Department of Laboratory Diagnostics, Institute of Medical Advanced Training FMBA of Russia


    • 2002 – 2014 Senior Research Fellow, Department of Fundamental and Applied Neurobiology, Serbsky National Research Centre for Social and Forensic Psychiatry
    • 2008 – 2009 Assistant Professor, Chair of Medical Nanobiotechnology, N.I. Pirogov Russian State Medical University
    • 2009 – 2016 Associate Professor, Chair of Medical Nanobiotechnology, N.I. Pirogov Russian State Medical University
    • 2014 – present time. Chief Scientific Officer Federal Research and Clinical Center, FMBA of Russia
    • 2016 - present time. Professor of the Department of Laboratory Diagnostics, Institute of Medical Advanced Training FMBA of Russia

    Scientific interests:
    • Neuroscience, Blood-Brain Barrier, Targeted Delivery into the Brain, Cell therapy of spinal cord injury, Cell therapy of Stroke
    • Tissue engineering of nervous system. Immunotherapy of solid tumors
    • Therapy of autoimmune diseases with T-regs
      London, UK
      Mark Lowdell
      PhD FRCPath FRSB
      Professor of Cell & Tissue Therapy at University College London
      Director of the Centre for Cell, Gene & Tissue Therapeutics
      Honorary Consultant Immunologist at Royal Free Hospital London
      Qualified diagnostic immunopathologist as well as holding MHRA Qualified Person status for the release of ATMPs for clinical trials
      Сurrent Vice President (Europe & Middle East) of the
      International Society for Cell Therapy



      Has over 20 years' experience in adoptive immunotherapy of cancer and has focussed on the role of the innate immune responses; especially the role of natural killer (NK) cells. Particularly interested in translational research and established the first academic GMP facility in the UK for the production of human cells as medicines in 2001. This GMP facility now produces somatic cell medicines, gene therapies and tissue engineered products. Professor Lowdell led the technology transfer of his own adoptive NK cell therapy product into three commercial CMOs in the US and was the chief scientific officer for the US clinical trial.

      His interest in clinical translation of cell and tissue therapies led to him being responsible for the first GMP-compliant stem cell-derived airway transplant produced as an ATMP in the EU and he now holds >£12m funding to perform formal clinical trials of stem cell derived trachea and larynx as well as the first UK clinical trial of an iPS cell-derived product. His newly refurbished ATMP GMP suite at RFH consists of 10 state-of-the-art manufacturing labs and over 20 staff supporting multiple academic and commercial trials.

      Scientific awards and memberships
      Professor Lowdell has held and holds numerous appointments to academic and government advisory boards in the UK and overseas. Recently he was a member of the UK Government Regenerative Medicine Expert Review Group and is a member of the scientific advisory boards, consultant to or founder of many of the key companies involved in ATMP development in the EU and USA including Autolus Ltd, Achilles Therapeutics Ltd, Cell Medica Ltd, InmuneBio Inc, NWBio Therapeutics.
      Münster, Germany
      Hans Schöler
      Director and Scientific Member at the Max Planck Institute for Molecular Biomedicine


      • 1985 - Studies in biology in Heidelberg, doctorate
      • 1994 - German Habilitation in molecular biology Ruprecht Karl University Heidelberg
      • 1991-1999 - Head of a research group at EMBL Heidelberg
      • 1999-2004 - Full Professor of Reproduction Physiology at the School of Veterinary Medicine and Director of the Center of Animal Transgenesis and Germ Cell Research at the University of Pennsylvania/USA
      • Since 2004 - Adjunct Professor of Biochemistry, University of Pennsylvania, School of Veterinary Medicine, Department of Animal Biology, Philadelphia/USA
      • Since 2003 - Director and Scientific Member at the Max Planck Institute for Molecular Biomedicine

      Scientific awards and memberships
      • 2004 - Member of "Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften"
      • 2005-2013 - Head of the Managing Board of the Stem Cell Network North Rhine Westphalia
      • 2005 - Member of the "Nordrhein-Westfälische Akademie der Wissenschaften" (North Rhine-Westphalian Academy of Sciences)
      • Since July 2005 - Member in the "Zentrale Ethik-Kommission für Stammzellenforschung"
      • 2008 - Robert Koch Prize
      • 2010 - Extraordinary Member of the Berlin-Brandenburg Academy of Sciences and Humanities
      • 2010 - Corresponding Member of the Academy of Sciences and Literature Mainz
      Munich, Germany
      Dominik Paquet
      Dr. rer. nat.
      Professor of Neurobiology, Ludwig-Maximilians University (LMU), Munich
      Head of research group in the Institute for Stroke and Dementia Research


      • 2011-2016 - Postdoctoral Fellow, Laboratory for Brain Development and Repair, The Rockefeller University, New York
      • 2009-2011 - Postdoctoral Fellow, German Center for Neurodegenerative Diseases, Munich
      • 2005-2009 - PhD Thesis (summa cum laude), Department of Biochemistry, Adolf-Butenandt-Institute, Ludwig-Maximilians University, Munich
      • 2004-2005 - Diploma Thesis, MRC Centre for Developmental Genetics, University of Sheffield
      • 1999-2004 - Studies of Biology (summa cum laude), University of Tuebingen

      Prof. Dr. rer. nat. Dominik Paquet headed a research group in the Institute for Stroke and Dementia Research in the end on 2016. He was appointed Professor for Neurobiology and is a member of the Munich Cluster for Systems Neurology (SyNergy). Following his PhD at the LMU Munich, Prof. Paquet worked as a New York Stem Cell Foundation Druckenmiller Fellow in the laboratory of Marc Tessier-Lavigne, where he pioneered the use of CRISPR/Cas9 gene editing in induced pluripotent stem cells to study diseases of the human brain.

      His research at the ISD is focused on the molecular and cellular mechanisms leading to neuronal death and cognitive decline in patients with neuropsychiatric disorders (e.g. Alzheimer's disease and Frontotemporal dementia) and neurovascular impairments (stroke and vascular cognitive impairment). He plans to build advanced human in vitro model systems based on patient-derived cells that recapitulate major disease hallmarks, and thus facilitate molecular studies and accelerate the identification of novel therapeutic approaches.

      Research interests
      • molecular and cellular mechanisms leading to neuronal death and cognitive decline in patients with neuropsychiatric disorders
      • neurovascular impairments
        Luxembourg, Belgium
        Jens Christian Schwamborn
        Université du Luxembourg, Faculté des Sciences, de la Technologie et de la Communication
        Principal Investigator in the Developmental & Cellular Biology group (Schwamborn Lab)

        Since 2013 Jens C. Schwamborn, PhD, is head of the Developmental and Cellular Biology group at the Luxembourg Centre for Systems Biomedicine as well as Professor at the University of Luxembourg. Additionally, since 2016 Jens is Chief Scientific Officer of the biotech company Braingineering Technologies SARL.
        In 2002 Jens obtained a diploma in Biochemistry from the University Witten/Herdecke in Germany and in 2005 a PhD in Biology from the University Muenster in Germany. He worked as a postdoctoral researcher at the Institute for Molecular Biotechnology in Vienna / Austria.

        The focus of his work over the last years was on Neurobiology, Stem Cell research and Parkinson's disease. In particular he is interested in using human induced pluripotent stem cells for the development of advanced approaches for in vitro disease modeling. Jens published more than 50 papers in peer reviewed journals, holds several patents and severs as reviewer for numerous journals and funding agencies.

        Research Interests:


        • Parkinson's disease
        • Systems Biomedicine
        • Stem Cells
        • Neurogenesis
        • Regeneration
        London, UK
        Stephen Sullivan
        PhD MBA FRSM

        Dr Sullivan earned his PhD at the Roslin Institute (Edinburgh) under Professor Ian Wilmut and Dr Jim McWhir, becoming one of the first researchers in Europe to culture human embryonic stem cells. His work focused on pluripotency induction in human somatic cells. Thereafter, Dr Sullivan worked as a Research Fellow at the University of Cambridge, Harvard University, and UCSD deepening his expertise of other human stem cell types (including induced pluripotent stem cells) and their applications for human medicine. While at Harvard, he read 'How Economics Shapes Science' by Paula Stefan, which stimulated his interest in the financial, as well as the scientific and medical, hurdles that must be surmounted to bring stem cell therapies to the clinic.

        He also worked for Novartis, dealing with clinical trial management and compliance, to better understand the Industrial perspective on bringing novel therapies to market. Thereafter, he earned an MBA at Trinity College Dublin focusing on risk mitigation within the nascent pluripotent stem cell market. From 2008-2017, Dr Sullivan was the Chief Scientific Officer of the Irish Stem Cell Foundation, where working with others, he facilitated the introduction of stem cell legislation into the Irish Program for Government. He is an honorary associate of the Scottish National Blood Transfusion Service, a member of Human Pluripotent Stem Cell Advisory Committee at University College Cork, and Chief Editor of 'Human Embryonic Stem Cells – The Practical Handbook' published by Wiley & Sons.

        In June 2017, Dr Sullivan joined GAiT, a new initiative supporting implementation and clinical application of therapies derived from pluripotent stem cells for the benefit of patients globally. GAiT is supported by an international consortium of organisations including the Cell and Gene Therapy Catapult (London, UK), the Centre for Commercialisation of Regenerative Medicine (Toronto, Canada), the Korea HLA-Typed iPSC Banking Initiative (Seoul, Korea) and the New York Stem Cell Foundation (New York, USA).

        Scientific awards and memberships
        • Honorary associate of the Scottish National Blood Transfusion Service
        • Member of Human Pluripotent Stem Cell Advisory Committee at University College Cork
        • Chief Editor of "Human Embryonic Stem Cells – The Practical Handbook"
        • Global Alliance for iPSC Therapies member
        St. Petersburg, Russia
        Alexey Tomilin
        Ph.D. Sci.D. Corresponding Member of the Russian Academy of Sciences
        Head of Laboratory of the Molecular Biology of Stem Cells, Institute of Cytology RAS


        Dr. Alexey Tomilin has broad interests in cell and molecular biology with a primary focus on pluripotent stem cells, such as embryonic stem (ES) and induced pluripotent stem (iPS) cells. Studying molecular mechanisms of stem cell maintenance and development is his primary focus, however, he also develops applications of pluripotent stem cells in clinics.

        • 1987-1992 Master Degree, Physics School, Polytechnical University, St-Petersburg
        • 1992-1997 Post-graduate training, Institute of Cytology, RAS, St-Petersburg and University of Caen, France; Ph.Ds. (Russian and French)
        • 1998: EMBO post-doctoral fellowship
        • 1998-1999 post-doctoral training, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
        • 1999-2002 post-doctoral training, School of Veterinary Medicine, University of Pennsylvania, USA
        • 2002-2006 Junior group leader, Dept. Developmental Biology, Max-Planck Institute for Immunobiology, Freiburg, Germany
        • 2007-now Lab leader, Institute of Cytology RAS, St-Petersburg
        • 2009 D.Sc. degree
        • 2011 Elected Corresponding Member of the Russian Academy of Science
        • 2009-now Member of scientific and thesis defence board of the Institute of Cytology RAS
        • 2009-2016 Advisory Board member of the Int. Rev. Cell Mol. Biol.
        • 2011 Elected corresponding member of the RAS
        • 2013 Member of the progmam committee of the FEBS-2013
        • 2013-now Member of the Expert Board of the Russian Foundation of Basic Research;
        • 2014-now Member of Expert Board of the Russian Science Foundation;
        • 2014 Expert of the Presidium of the RAS programme "Fundamental research for the development of biomedical technologies"
        • 2014-now Member of Scientific Council of the Ministry of Health;
        • 2016 Сhair of the conference "Recent Achievements in Stem Cells Research", April 6-8, 2016, St. Petersburg, Russia
        • 2016 Member of selection committee of the 12-th International Congress of Cell Biology (ICCB 2016), Praha
        • 2016 Honorary medal "Silver Sigma" (Siberian Branch of the Russian Acad. Sci.)
        • 2017 Honorary Diploma of the Russian Academy of Sciences "For conscientious work, great contribution to the development of fundamental and applied science, in connection with the 60th anniversary of the foundation of the Institute of Cytology"
        • 2017 Member of program committee of the III National Congress of Regenerative Medicine, November 15-18, 2018, Moscow, Russia.
          Moscow, Russia
          Andrey Vasiliev
          Prof., Sci. Dr.
          Director of Koltzov Institute of Developmental Biology of Russian Academy of Sciences


          Scientific interests
          • mechanisms of tissue repair
          • regenerative medicine
          Novosibirsk, Russia
          Oleg Serov
          Dr. Sci. (Biol.)
          Head of Laboratory of Developmental Genetics, Sector of Embryonal Stem Cell Genomics, Institute of Cytology and Genetics, Novosibirsk

            Moscow, Russia
            Maria Lagarkova
            Dr. Sci.(Biol.)
            Vavilov Institute of General Genetics, Laboratory of Stem Cell Biology
            Head of the Laboratory of Cell Biology at the Research Center of Physical-Chemical Medicine in Moscow.


            Graduated from the Lomonosov Moscow State University. She defended her PhD thesis "New approaches to study the loop organization of chromosomes" in 1995. For many years Maria Lagarkova works in the field of stem cell biology. She is a head of the Laboratory of Cell Biology at the Research Center of Physical-Chemical Medicine in Moscow. The basic directions of Maria Andreevna's scientific research are the study of the mechanisms of differentiation and epigenetics of pluripotent stem cells and the modeling of neurodegenerative diseases with induced pluripotent stem cells.

            Research interests
            • mechanisms of differentiation and epigenetics of pluripotent stem cells
            • neurodegenerative diseases with induced pluripotent stem cells


            St. Petersburg, Russia
            Anna Malashicheva
            PhD
            Head of laboratory of Molecular Cardiology, Federal Almazov Medical Research Centre
            Associate Professor, Dept. of Embryology, Biological Faculty, St.-Petersburg State University


            Research interests
            • developmental biology
            • cellular and molecular biology of stem cells
            • translational medicine

            Ongoing projects in the laboratory
            • Lineage specific function of Notch signaling in the cardiovascular system, role of Notch signaling in aortic diseases and congenital heart diseases
            • Modeling of cardiomyopathies with patient-specific induced pluripotent stem cells
            • Notch in osteogenic differentiation.
            Moscow, Russia
            Erdem Dashinimaev
            PhD
            Koltzov Institute of Developmental Biology, RAS

            Graduated from Moscow Institute of Physics and Technologics (MIPT), Department of Molecular Biology and Physics. Defended thesis on the creation of immortalized cultures of human stem and progenitor cells by telomerase activation. At this moment works at the Koltsov Institute of Developmental Biology in the laboratory of cell biology.

            Research interests
            • stem cells
            • regenerative medicine
            • genome editing
            Villejuif, France
            Yegor Vassetzky
            PhD, Researcher
            CNRS research director
            Head of the laboratory of Nuclear Organization and Pathologies at the Institut Gustave Roussy
            Head of a Joint French-Russian Oncology Research Laboratory
            Director, Joint French-Russian Cancer Research Laboratory


            Graduated from the Moscow State University in 1984. After a PhD thesis in 1989, he worked as a postdoctoral fellow in Paris, Lausanne and Montpellier. Since 2002 he heads the Nuclear Organization and Pathologies laboratory at the Gustave Roussy Institute (Villejuif, France). His main research interests concern epigenetic regulation and nuclear organization in genetic diseases and cancers. He has more than 130 publications in peer-reviewed journals.

            Education:
            • 1985 - B.Sc., Department of Molecular Biology, State University of Moscow. Field: Biochemistry
            • 1989 - Ph.D., Institute of Molecular Biology, USSR Academy of Sciences, Moscow. Field: Molecular Biology
            • 1997 - Dr. Sci., Institute of Developmental Biology, Russian Academy of Sciences, Moscow. Field: Developmental Biology

            Teaching Activities:
            • 2005-present Master II course at the Paris Sud University
            • 2007-2012 Master II course at the Versailles University
            • 2014 Member of the selection committee, CBS2 PhD School, Montpellier
            • 2015-present Master II course at the Pierre and Marie Curie University, Paris

            Other Activities:
            • 2011-present Member of the Board of Directors, Affitech SA (NASDAQ OMX: AFFI)
            • 2012-2015 Chairman of the International Scientific Advisory Board, Institute of Molecular Biology and Genetics, Kiev, Ukraine
            • 2013-2016 Chairman of the Biology section, Dynasty charity fund
            • 2015-present Member of the International Committee, Wilhelm Bernhard Workshop

            Research interests
            • Epigenetic regulation and nuclear organization in genetic diseases and cancers
            Cardiff, UK
            Philip Stephens
            Professor of Cell Biology and Dean of International for the College of Biomedical and Life Sciences at Cardiff University
            HTA Designated Individual
            Cardiff University Biobank academic lead
            President of the European Tissue Repair Society

            College of Biomedical & Life Sciences, Cardiff University

            Professor Phil Stephens is currently Professor of Cell Biology and Dean of International for the College of Biomedical and Life Sciences at Cardiff University. He moved to Cardiff University in 1994 as Post Doctoral Researcher having obtained a first class honours degree and a PhD from Leeds University. Subsequently he established the Wound Biology Group with a clinical colleague. He was previously Vice Dean (Research) at the School of Dentistry, Cardiff University and Chair of the Cardiff Institute of Tissue Engineering and Repair.

            His research interests are in the fields of oral progenitor cells, differential wound healing, ageing, tissue engineering, animal replacement model systems and cellular imaging. Within these areas he has managed research projects (Research Council, Charity and Industry) totalling over £4.5 Million, published widely, obtained patents and his group has won many National and International prizes.

            Externally he works closely with organisations such as the National Centre for the Replacement, Refinement and Reduction of Animals in Research and reviews grant applications and manuscripts for numerous national and international funders/journals. He is currently setting up an overarching tissue biobank at Cardiff University to support research in both academic and industrial settings.


            Research interests
            • oral progenitor cells
            • differential wound healing
            • ageing
            • tissue engineering
            • animal replacement model systems
            • cellular imaging
            Moscow, Russia
            Alexander Fedulov
            Moscow Regional Research Clinical Institute

            In 2013 won of the "UMNIK" program with topic: "A new technique of treating infertility and restore of male testosterone generative function." Since 2015 - a scientific employee in the Department of Pediatric Surgery in the "Moscow Regional Research Clinical Institute". Member of the group of regenerative medicine in the "Moscow Regional Research Clinical Institute".

            At the moment, the scientific work is devoted to research of the effect of vitalized and non-vitalized biodegradable implants of various compositions on regeneration of the gastrointestinal tract, when it is damaged, in experiment.

            Research interests
            • regenerative medicine
            • cellular technologies
            • biodegradable implants
            • reconstructive operations on gastrointestinal tract
            Moscow, Russia
            Konstantin Yarygin
            PhD, MD
            Head of the Cell Biology Lab at IBMC, Moscow, Russia
            Professor at the Department of Pathophysiology at the Russian Medical Academy of Postgraduate Education

            Academic Experience:
            • 1974 to 1996 – USSR Cardiology Research Center, Moscow, Russia
            • 1996-1998 – Geraldine Brush Cancer Research Institute, California Pacific Medical Center, San Francisco, CA
            • 1998-present - V.N.Orekhovich Institute of Biomedical Chemistry (IBMC), Moscow, Russia
            • 2003-2007 – Russian State Medical University, Moscow, Russia
            • 2013–present – Russian Medical Academy of Postgraduate Education, Moscow, Russia

            Research Interests:
            • regenerative medicine
            • cell biology
            • stem cells
              Moscow, Russia
              Natalia Kalinina
              Leading research scientist in the Department of Biochemistry and Molecular Medicine, Faculty of Medicine, M.V. Lomonosov Moscow State University

              Graduated summa cum laude from Faculty of Biology, M.V. Lomonosov Moscow State University in 1997. In 2001, she got her PhD from Cardiology Research Center, Moscow, Russia. Currently she is a leading research scientist in the Department of Biochemistry and Molecular Medicine, Faculty of Medicine, M.V. Lomonosov Moscow State University.

              Studies of Dr. Kalinina are focused on cellular and molecular mechanisms of tissue regeneration; stem and progenitor cell physiology. In this field she has published over 50 articles, co-author of 19 RF patents.

              She was awarded by Rector stipend to young teachers and scientist achieved a significant success in teaching and research (2005 and 2007).

              Research interests
              • cellular and molecular mechanisms of tissue regeneration
              • stem and progenitor cell physiology
              Moscow, Russia
              Ekaterina Vorotelyak
              PhD
              Head of the Cellular Biology laboratory at N.K. Koltzov Institute of Developmental Biology RAS
              Associate Professor at Moscow State University
              Head of the Department of Regenerative Medicine in Pirogov Russian National Research Medical University
              Corresponding member of Russian Academy of Sciences


              In 1993 Vorotelyak obtained a diploma in Cell Biology and Histology from Moscow State University and in 1998 a PhD in Biology. She worked as postdoctoral fellow in N.K. Koltzov Institute of Developmental Biology of Russian Academy of Sciences in Moscow. In 2016, she was elected as a Corresponding member of Russian Academy of Sciences.

              In recent years she focused on epidermal and hair follicle morphogenesis, mesenchymal and epidermal stem cells in the skin and development of new technologies for regenerative medicine. Vorotelyak published more than 60 papers in peer reviewed journals, holds several patents and severs as reviewer for numerous funding agencies.

              Research inrerests
              • epidermal and hair follicle morphogenesis
              • mesenchymal and epidermal stem cells in the skin
              • development of new technologies for regenerative medicine
              Conference Program
              Wednesday, April 11
              Thursday, April 12
              Friday, April 13
              11 April | Wednesday
              OPENING SESSION
              12 April | Thursday
              BASIC PROBLEMS OF CELL RESEARCH
              CELLULAR MODELS OF HUMAN DISEASES
              ORGANOIDS AND TISSUES ENGINEERING
              Poster session
              13 April | Friday
              GENOME EDITING
              BEST PRACTICE IN CELL THERAPY AND CELL PRODUCTS DEVELOPMENT
              perspectives and CHALLENGES IN biomedical CELL TECHNOLOGy development
              Commitees
              CHAIRS
              Prof. Andrey Vasiliev — сhair
              Ph.D., Sci.D., Corresponding member of the Russian Academy of Sciences, Director of Koltzov Institute of Developmental Biology RAS

              Dr. Alexey Tomilin — сo-сhair
              Ph.D., Sci.D., Corresponding member of the Russian Academy of Sciences, Head of Laboratory Molecular Biology of Stem Cells, Institute of Cytology RAS

              Olga Seredkina — сo-сhair
              General Manager, OPTEC Company
              INTERNATIONAL ADVISORY BOARD
              Prof. Nikolay Nikolsky
              Sci.D., Academician of the Russian Academy of Sciences, Institute of Cytology RAS, St. Petersburg, Russia

              Alexey Bersenev
              Director, Advanced Cell Therapy Lab at Yale University Greater New York City Area

              Prof. Dr. Hans Schöler
              Max Planck Institute for Molecular Biomedicine, Münster
              PROGRAM COMMITEE
              Dr. Alexey Tomilin, Head of Program Committee
              Ph.D., Sci.D., Corresponding member of the Russian Academy of Sciences, Head of Laboratory Molecular Biology of Stem Cells, Institute of Cytology RAS

              Dr. Ekaterina Vorotelyak
              Ph.D., Sci.D., Corresponding member of the Russian Academy of Sciences, Head of Laboratory of cell biology, N.K. Koltzov Institute of Developmental Biology, RAS

              Dr. Natalia Mikhailova
              Ph.D., Sci.D., Head of Cell Technologies Center, Institute of Cytology of the Russian Academy of Sciences, St.Petersburg, Russia

              Prof. Maria Alexandrova
              PhD., Sci D., Head of the Group of Experimental Neurobiology, N.K. Koltzov Institute of Developmental Biology, RAS

              Tamara Malygina
              Head of Cell Technologies SBU, OPTEC, St. Petersburg, Russia
              Payment
              The cost of participation in the conference depends on the dates and will increase 2 March, 2018. If you are postgraduate and have a student card, find special prices below.
              2000 rubles

              Early birds payment
              Till 1 March, 2018
              For postgraduates with student card only

              Pay now >>
              2500 rubles

              Standard fee
              Till April 10

              For postgraduates with student card only

              Pay now >>
              4000 rubles

              Early birds payment
              Till March 1

              Pay now >>

              5500 rubles

              Standard fee
              Till April 10

              Pay now >>
              How can I pay?
              Please pay the registration fee by using the following details. Before the payment make sure of receiving confirmation of your participation from organizers. After the payment please send us the scanned copy of your payment receipt.

              Name of the organization: OPTEC LLC
              Legal address: Russia, 105005, Moscow, Denisovsky lane 26
              INN/KPP: 7701234835/770101001
              Bank details: COMMERZBANK (EURASIJA) AO
              BIC: 044525105
              Corr. account: 30101810300000000105
              Settlement account: 40702810900002000214
              Purpose of Payment: "Участие в конференции CTERP"


              It is possible to conclude an agreement for participation in the conference.


              To pay by a legal entity, please send us the details of payer organization and application with the list of participants.

              Venue
              CTERP Conference takes place in Novotel Moscow City. It's a part of The Moscow International Business Centre and located on the Presnenskaya embankment of the Moscow River, approximately 4 kilometers west of Red Square, and just east of the Third Ring Road.

              Presnenskaya Naberezhnaya 2
              MOSCOW - RUSSIAN FEDERATION
              GPS. N 55° 44' 53.05'' E 37° 32' 12.66''
              Registration
              Registration for visitors is open till 31 March
              For speakers - till 28 February

              If you would like to present your work on the conference – please, read the requirements for theses and don't forget to attach your abstract submission
              Your first name
              Last name
              Email
              Phone
              Organization
              City
              Type of participation
              Please upload your abstract submission here
              Conference is supported by
              Grant number 18-04-20012
              Provides targeted diversified support to leading groups of scientists for researches in all the principal directions of fundamental science
              Sponsors
              Organizators
              Organizing committee
              Feel free to contact us: cterp@optecgroup.com

              Ekaterina Kutuzova
              Head of Marketing, OPTEC, Moscow, Russia

              Marina Habarova
              Academic Secretary, N.K. Koltzov Institute of Developmental Biology, Moscow, Russia

              Juliya Smirnova
              N.K. Koltzov Institute of Developmental Biology, Moscow, Russia

              Ekaterina Volina
              N.K. Koltzov Institute of Developmental Biology, Moscow, Russia

              Mikhail Khotin
              PhD, Research Fellow, Institute of Cytology RAS, St.Petersburg, Russia

              Anna Koltsova
              Institute of Cytology RAS, St.Petersburg, Russia